Correspondence 0001437749-23-032438 from INTEST CORP (INTT) (CIK 0001036262) (INTT)
INTEST CORP (INTT) (CIK 0001036262)
Date: Nov. 17, 2023 · CIK: 0001036262 · Accession: 0001437749-23-032438
AI Filing Summary & Sentiment
File numbers found in text: 333-275451
Show Raw Text
CORRESP 1 filename1.htm intt20231117_corresp.htm inTEST Corporation 804 East Gate Drive, Suite 200 Mt. Laurel, New Jersey 08054 November 17, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Margaret Schwartz Re: inTEST Corporation Registration Statement on Form S-3 Filed November 9, 2023 File No. 333-275451 Ladies and Gentlemen: In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, inTEST Corporation, a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the registration statement on Form S-3 (File No. 333-275451), filed with the U.S. Securities and Exchange Commission on November 9, 2023, be accelerated so that the registration statement becomes effective at 4:00 p.m. Eastern Time on November 20, 2023 or as soon thereafter as practicable. If you have any questions or comments, please contact Alexander R. McClean of Harter Secrest & Emery at (585) 231-1248. Very truly yours, inTEST Corporation By: /s/ Richard N. Grant, Jr. Richard N. Grant, Jr. President and Chief Executive Officer